 Small proof-of-concept clinical trials in cancer patients indicate that the efficacy of anti-cancer vaccines may indeed be enhanced by chemotherapy 2. Also preliminary observations indicate that chemotherapeutic agents, in particular platinum compounds cisplatin, carboplatin and oxaliplatin are immunogenic and may contribute to reverse tumor cell induced immunosuppressionimmune deviation. 